Table of Contents Author Guidelines Submit a Manuscript
Case Reports in Immunology
Volume 2016, Article ID 9165641, 4 pages
http://dx.doi.org/10.1155/2016/9165641
Case Report

Differential Impairment of Interferon-γ Responses in Two Cases of Pulmonary Nontuberculous Mycobacterial Disease

1University Hospital Southampton NHS Foundation Trust, Southampton, UK
2Academic Unit of Cancer Sciences, Faculty of Medicine, University of Southampton and Southampton NIHR Experimental Cancer Medicine Centre, Southampton, UK
3Department of Clinical Biochemistry and Immunology, Addenbrooke’s Hospital, Cambridge, UK
4National Institute for Health Research, Cambridge Biomedical Research Centre, Cambridge, UK

Received 13 July 2016; Revised 13 October 2016; Accepted 26 October 2016

Academic Editor: Jiri Litzman

Copyright © 2016 William Rae et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. J.-L. Casanova and L. Abel, “Genetic dissection of immunity to mycobacteria: the human model,” Annual Review of Immunology, vol. 20, pp. 581–620, 2002. View at Publisher · View at Google Scholar · View at Scopus
  2. J. Bustamante, C. Picard, S. Boisson-Dupuis, L. Abel, and J.-L. Casanova, “Genetic lessons learned from X-linked Mendelian susceptibility to mycobacterial diseases,” Annals of the New York Academy of Sciences, vol. 1246, no. 1, pp. 92–101, 2011. View at Publisher · View at Google Scholar · View at Scopus
  3. T. Ishii, A. Tamura, H. Matsui et al., “Disseminated Mycobacterium avium complex infection in a patient carrying autoantibody to interferon-γ,” Journal of Infection and Chemotherapy, vol. 19, no. 6, pp. 1152–1157, 2013. View at Publisher · View at Google Scholar · View at Scopus
  4. U.-I. Wu and S. M. Holland, “Host susceptibility to non-tuberculous mycobacterial infections,” The Lancet Infectious Diseases, vol. 15, no. 8, pp. 968–980, 2015. View at Publisher · View at Google Scholar · View at Scopus
  5. E. P. Szymanski, J. M. Leung, C. J. Fowler et al., “Pulmonary nontuberculous mycobacterial infection. A multisystem, multigenic disease,” American Journal of Respiratory and Critical Care Medicine, vol. 192, no. 5, pp. 618–628, 2015. View at Publisher · View at Google Scholar · View at Scopus
  6. M. Fleshner, K. N. Olivier, P. A. Shaw et al., “Mortality among patients with pulmonary non-tuberculous mycobacteria disease,” The International Journal of Tuberculosis and Lung Disease, vol. 20, no. 5, pp. 582–587, 2016. View at Publisher · View at Google Scholar
  7. S. Novosad, E. Henkle, and K. L. Winthrop, “The challenge of pulmonary nontuberculous mycobacterial infection,” Current Pulmonology Reports, vol. 4, no. 3, pp. 152–161, 2015. View at Publisher · View at Google Scholar
  8. M. Kartalija, A. R. Ovrutsky, C. L. Bryan et al., “Patients with nontuberculous mycobacterial lung disease exhibit unique body and immune phenotypes,” American Journal of Respiratory and Critical Care Medicine, vol. 187, no. 2, pp. 197–205, 2013. View at Publisher · View at Google Scholar · View at Scopus
  9. U. Greinert, M. Schlaak, S. Rũsch-Gerdes, H.-D. Flad, and M. Ernst, “Low in vitro production of interferon-γ and tumor necrosis factor-α in HIV-seronegative patients with pulmonary disease caused by nontuberculous mycobacteria,” Journal of Clinical Immunology, vol. 20, no. 6, pp. 445–452, 2000. View at Publisher · View at Google Scholar · View at Scopus
  10. Y. S. Kwon, E. J. Kim, S.-H. Lee et al., “Decreased cytokine production in patients with nontuberculous mycobacterial lung disease,” Lung, vol. 185, no. 6, pp. 337–341, 2007. View at Publisher · View at Google Scholar · View at Scopus